![Alfredo Zurlo](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Alfredo Zurlo
No más puestos en curso
Perfil
Alfredo Zurlo served as Co-Managing Director at Glycotope GmbH.
He then worked as Chief Medical Officer at MOLOGEN AG from 2013 to 2016.
After that, he served as Chief Medical Officer at Scandion Oncology A. Zurlo holds a doctorate degree from The American University of Rome.
Antiguos cargos conocidos de Alfredo Zurlo.
| Empresas | Cargo | Fin |
|---|---|---|
| MOLOGEN AG | Director Técnico/Científico/I+D | 31/03/2016 |
| SCANDION ONCOLOGY A/S | Director Técnico/Científico/I+D | - |
Glycotope GmbH
 Glycotope GmbH Data Processing ServicesTechnology Services Provides hosting, web development and UX design services | Director Ejecutivo | - |
Formación de Alfredo Zurlo.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
5
Relaciones de 1er grado
4
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 4 |
|---|---|
The American University of Rome
 The American University of Rome Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
MOLOGEN AG
 MOLOGEN AG Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops immunotherapies for the treatment of infectious diseases | Health Technology |
Glycotope GmbH
Glycotope GmbH Data Processing ServicesTechnology Services Provides hosting, web development and UX design services | Technology Services |
Scandion Oncology A/S
 Scandion Oncology A/S Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs for chemotherapy resistance mechanisms | Health Technology |
- Bolsa de valores
- Insiders
- Alfredo Zurlo
